Study advances possible blood test for early-stage Alzheimer's disease, explains why women may be at higher risk
Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer's disease, ...
This Promising New Alzheimer's Study Could Unlock a Massive Growth Opportunity for Novo Nordisk and Eli Lilly
Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are two of the most valuable healthcare stocks in the world, largely due ...
STAT20h
Using lab-grown human mini-brains, scientists find links between head trauma, herpes, and Alzheimer’s
Research published Tuesday is the first to connect the dots between a common herpes virus, head injury, and Alzheimer's.
Why Alzheimer’s Scientists Are Re-thinking the Amyloid Hypothesis
For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...
New Study Finds Link Between This Common Virus and Alzheimer’s Disease: What A Neurologist Wants You To Know
The researchers found the presence of CMV antibodies all over patients with Alzheimer's disease, including the intestines, ...
How a Common Virus Could Trigger Alzheimer’s Disease
Researchers have linked herpes simplex virus-1 with Alzheimer's disease, revealing a surprising potential viral trigger for the neurodegenerative condition. Their study suggests that the tau protein, ...
Seth Rogen and Wife Lauren Miller Recall ‘Brutal’ Time Navigating Her Mother’s Alzheimer’s in New Doc (Exclusive)
I've seen firsthand how people sharing their stories is very therapeutic and allows other people to open up themselves,” Seth ...
Johnson & Johnson Gets FDA Fast-Track Designation for Posdinemab in Alzheimer's
The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...
Johnson & Johnson's Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer's Disease
Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to posdinemab, a phosphorylated tau-directed monoclonal antibody (mAb) ...
IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer’s Agitation “CALMA” and Expands Recruitment Strategy
POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...
Could This Be the Cure? Targeting Protein Imbalances To Stop Alzheimer’s
Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...
HealthDay on MSN7h
More Evidence Bolsters the Oral Herpes and Alzheimer’s Link
That cold sore on your lip might be painful and unsightly, but it could also be a harbinger of debilitating brain agin ...